已收盘 04-02 16:00:00 美东时间
-0.580
-8.68%
今日重点评级关注:Freedom Capital Markets:维持LifeMD"买入"评级,目标价从8美元升至10美元;Chardan Capital:维持Opus Genetics"买入"评级,目标价从9美元升至11美元
03-13 09:59
Exodus Movement (AMEX:EXOD) reported mixed Q4 results with earnings beating estimates but sales falling short. Shares rose 15.3% to $9.24.
03-13 00:56
BTIG analyst Andrew Harte maintains Exodus Movement (AMEX:EXOD) with a Buy and lowers the price target from $30 to $20.
03-12 19:08
Exodus Movement (AMEX:EXOD) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.12 by 200 percent. This is a 82.69 percent decrease over earnings of $2.08 per share from the
03-12 05:42
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
Exodus Movement (AMEX:EXOD) is set to give its latest quarterly earnings report...
03-10 23:02
Shares of software companies are trading higher after JPMorgan strategists sugg...
02-11 02:32
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
BTIG analyst Andrew Harte maintains Exodus Movement (AMEX:EXOD) with a Buy and lowers the price target from $40 to $30.
01-09 02:45
今日重点评级关注:Ascendiant Capital:维持Society Pass"买入"评级,目标价从22美元升至22.5美元;HC Wainwright & Co.:维持Climb Bio"买入"评级,目标价从9美元升至11美元
2025-12-19 10:15